1. PINEIRO-CARRERO V M, PINEIRO E O. Liver. PEDIATRICS 2004; 113(4 Suppl): 1097-106.
2. DONG M H, BETTENCOURT R, BARRETT-CONNOR E, LOOMBA R. Alanine aminotransferase decreases with age: the Rancho Bernardo Study. PLOS ONE 2010; 5(12): e14254.
3. SCHMUCKER D L. Age-related changes in liver structure and function: Implications for disease ? EXP GERONTOL 2005; 40(8-9): 650-59.
4. MINEMURA M, SHIMIZU Y. Gut microbiota and liver diseases. World J Gastroenterol 2015; 21(6): 1691-702.
5. MENDENHALL C L. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am J Dig Dis 1968; 13(9): 783-91.
6. MANDAYAM S, JAMAL M M, MORGAN T R. Epidemiology of alcoholic liver disease. SEMIN LIVER DIS 2004; 24(3): 217-32.
7. LEE S, LEE H, KIM S, LEE J, HA J, CHOI Y, et al. Intestinal Clostridioides difficile Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes. BIOMED RES INT 2020; 2020: 7929610.
8. ARORA N, GOLDHABER S Z. Anticoagulants and transaminase elevation. CIRCULATION 2006; 113(15): e698-702.
9. SERVICES. U S D O. Common Terminology Criteria for Adverse Events( CTCAE) Version 4. 02[ EB/OL]. 2009.
10. ALLEN L A, FELKER G M, POCOCK S, MCMURRAY J J, PFEFFER M A, SWEDBERG K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. EUR J HEART FAIL 2009; 11(2): 170-77.
11. van DEURSEN V M, DAMMAN K, HILLEGE H L, van BEEK A P, van VELDHUISEN D J, VOORS A A. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J CARD FAIL 2010; 16(1): 84-90.
12. BATIN P, WICKENS M, MCENTEGART D, FULLWOOD L, COWLEY A J. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. EUR HEART J 1995; 16(11): 1613-18.
13. ALLEN L A, FELKER G M, POCOCK S, MCMURRAY J J, PFEFFER M A, SWEDBERG K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. EUR J HEART FAIL 2009; 11(2): 170-77.
14. van DEURSEN V M, DAMMAN K, HILLEGE H L, van BEEK A P, van VELDHUISEN D J, VOORS A A. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J CARD FAIL 2010; 16(1): 84-90.
15. SCHOLFIELD M, SCHABATH M B, GUGLIN M. Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial. J CARD FAIL 2014; 20(7): 476-84.
16. KUBIK J F, GILL R S, LAFFIN M, KARMALI S. The impact of bariatric surgery on psychological health. J Obes 2013; 2013: 837989.
17. FONTAINE K R, REDDEN D T, WANG C, WESTFALL A O, ALLISON D B. Years of life lost due to obesity. JAMA 2003; 289(2): 187-93.
18. KAPLAN M S, HUGUET N, NEWSOM J T, MCFARLAND B H, LINDSAY J. Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian National Population Health Survey. J Gerontol A Biol Sci Med Sci 2003; 58(11): 1018-30.
19. HENSON J, YATES T, BIDDLE S J, EDWARDSON C L, KHUNTI K, WILMOT E G, et al. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. DIABETOLOGIA 2013; 56(5): 1012-20.
20. BISWAS A, OH P I, FAULKNER G E, BAJAJ R R, SILVER M A, MITCHELL M S, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. ANN INTERN MED 2015; 162(2): 123-32.
21. KNAEPS S, LEFEVRE J, WIJTZES A, CHARLIER R, MERTENS E, BOURGOIS J G. Independent Associations between Sedentary Time, Moderate-To-Vigorous Physical Activity, Cardiorespiratory Fitness and Cardio-Metabolic Health: A Cross-Sectional Study. PLOS ONE 2016; 11(7): e160166.
22. LEE I M, SHIROMA E J, LOBELO F, PUSKA P, BLAIR S N, KATZMARZYK P T. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. LANCET 2012; 380(9838): 219-29.
23. HENSON J, YATES T, BIDDLE S J, EDWARDSON C L, KHUNTI K, WILMOT E G, et al. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. DIABETOLOGIA 2013; 56(5): 1012-20.
24. SMITH A D, CRIPPA A, WOODCOCK J, BRAGE S. Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies. DIABETOLOGIA 2016; 59(12): 2527-45.
25. TREMBLAY M S, AUBERT S, BARNES J D, SAUNDERS T J, CARSON V, LATIMER-CHEUNG A E, et al. Sedentary Behavior Research Network (SBRN) - Terminology Consensus Project process and outcome. Int J Behav Nutr Phys Act 2017; 14(1): 75.
26. BLAIR S N, KOHL H R, PAFFENBARGER R J, CLARK D G, COOPER K H, GIBBONS L W. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989; 262(17): 2395-401.
27. BOWDEN D K, SPRUNG V S, NORMAN J A, THOMPSON A, MITCHELL K L, HARROLD J, et al. Physical Activity and Sedentary Time: Association with Metabolic Health and Liver Fat. Med Sci Sports Exerc 2019; 51(6): 1169-77.
28. FORTIER E, ALAVI M, BRUNEAU J, MICALLEF M, PERRAM J, SOCKALINGAM S, et al. Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia. J ADDICT MED 2017; 11(1): 10-18.
29. GOLDEN J, O'DWYER A M, CONROY R M. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 2005; 27(6): 431-38.
30. ROGAL S S, MANKANEY G, UDAWATTA V, CHINMAN M, GOOD C B, ZICKMUND S, et al. Pre-Transplant Depression Is Associated with Length of Hospitalization, Discharge Disposition, and Survival after Liver Transplantation. PLOS ONE 2016; 11(11): e165517.
31. SULLIVAN L E, FIELLIN D A, O'CONNOR P G. The prevalence and impact of alcohol problems in major depression: a systematic review. AM J MED 2005; 118(4): 330-41.
32. VOICAN C S, CORRUBLE E, NAVEAU S, PERLEMUTER G. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry 2014; 171(4): 404-15.